BIOCRYST PHARMACEUTICALS INC — Director's Dealing 2015

Sep 29, 2015

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIOCRYST PHARMACEUTICALS INC (BCRX)
CIK: 0000882796
Period of Report: 2015-09-25

Reporting Person: Patel Sanj K (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2015-09-25	Non-Qualified Stock Option	$11.18	A	16667	Acquired	2025-09-25	Common Stock (16667)	Direct

Footnotes

F1: Automatic non-employee director grant pursuant to the BioCryst Pharmaceuticals, Inc. Stock Incentive Plan (the "Plan").

F2: Vest 1/8 per month over eight months beginning October 25, 2015.